GPX4 and cancer: In addition, Lei et al.’s study revealed for the first time that breast cancer susceptibility gene 1 (BRCA1)‐deficient cancer cells were resistant to Erastin‐induced ferroptosis, but showed vulnerability to GPX4 inhibitors (GPX4i)‐induced ferroptosis [210].